Skip to main content

Table 1 Characteristics of study population (n = 3840)

From: Effective factors on Sharp Score in patients with rheumatoid arthritis: a retrospective study

Quantitative Variables

Mean

Standard Deviation

Age (years)

56.95

12.68

Symptom duration (years)

3.45

1.09

Disease duration (years)

6.92

1.20

BMI (Kg/m2)

22.80

4.51

Tender joint count, 0–28

10.73

5.63

 

Subjects

Percentage

Sharp score

 ≤ 0 score

111

2.89

 > 0 score, ≤ 50 score

2674

69.64

 > 50 score

1055

27.47

Gender

 Male

666

17.34

 Female

3174

82.66

Ever smoker

458

11.93

Ever drinker

582

15.16

RF positivity

3001

78.15

CCP positivity

3636

94.68

Presence of radiographic erosions

2162

56.32

Prednisolone use

2150

55.98

DMARD treatment (at baseline)

 DMARD-naive

3017

78.56

 MTX monotherapy

1368

35.62

 Non-MTX csDMARD

888

23.13

 Combination csDMARD

905

23.56

Education status

 None or primary

1545

40.23

 Secondary or vocational

1740

45.31

 Tertiary

555

14.45

Housing status

 Private housing

2397

62.42

 Government housing

1443

37.58

Employment status

 Currently employed

1735

45.18

 Unemployment, retired or homemaker

2105

54.82

Marital status

 Currently married

3657

95.23

 Single, divorced or widowed

183

4.77

 

Interquartile range (IQR)

Sharp score

20.00 (7.00, 56.00)

DAS28 score

5.50 (4.00, 7.28)

ESR (mm/h)

42.00 (22.00, 68.00)

CRP (mg/L)

15.82 (3.61, 41.49)

RF (U/ml)

79.15 (19.90, 195.05)

CCP (U/ml)

132.98 (25.00, 402.67)

IGA (g/L)

2.47 (1.87, 3.27)

IGG (g/L)

13.45 (11.00, 16.40)

IGM (g/L)

1.35 (0.91, 1.68)

C3 (g/L)

112.45 (96.50, 129.30)

C4 (g/L)

24.7 (19.20, 30.80)

BALP (ng/ml)

660.13 (431.37, 851.60)

BGP (ng/ml)

3479.49 (2871.84, 4825.99)

OPG (ng/ml)

117.20 (948.12, 1338.62)

RANKL (ng/ml)

1085.40 (955.51, 1322.46)

  1. Demographic and clinical variables of all participants were presented in mean (standard deviation), percentage or median (interquartile range)